Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $31.1 billion.

  • Sanofi's Total Non-Current Liabilities rose 1304.55% to $31.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $31.1 billion, marking a year-over-year increase of 1304.55%. This contributed to the annual value of $30.2 billion for FY2025, which is 834.59% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Total Non-Current Liabilities is $31.1 billion, which was up 1304.55% from $29.0 billion recorded in Q2 2025.
  • Sanofi's 5-year Total Non-Current Liabilities high stood at $35.9 billion for Q2 2021, and its period low was $27.5 billion during Q4 2024.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $30.0 billion (2023), whereas its average is $30.5 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 1773.16% in 2022, then surged by 1304.55% in 2025.
  • Sanofi's Total Non-Current Liabilities (Quarter) stood at $34.2 billion in 2021, then fell by 17.73% to $28.2 billion in 2022, then rose by 6.64% to $30.0 billion in 2023, then fell by 8.25% to $27.5 billion in 2024, then grew by 13.05% to $31.1 billion in 2025.
  • Its last three reported values are $31.1 billion in Q4 2025, $29.0 billion for Q2 2025, and $27.5 billion during Q4 2024.